As a result of changes to gene expression, the immune microenvironment is altered, presenting a significant therapeutic potential for tumors.[59,60] Further, we evaluated the correlation between the expression of FXR1 and the immune infiltration of cancer-associated fibroblasts in the TCGA across all cancer types. Here, FXR1 is linked to cancer.